Emcure Pharmaceuticals has entered into a strategic partnership with Sanofi India to market and distribute Sanofi’s well-established anti-diabetic portfolio across the country. The collaboration is set to significantly enhance Emcure’s presence in the burgeoning diabetes care segment, while enabling Sanofi to widen the reach of its trusted brands. This alliance comes at a time when India faces an alarming surge in diabetes prevalence, creating a pressing need for greater access to quality therapies.
